Update: SAHPRA Approves Lenacapavir For HIV Prevention

SAHPRA Approves Lenacapavir For HIV Prevention

SAHPRA's approval for lenacapavir is crucial for the country to begin drug rollout, expected by April 2026.

Meanwhile, in other news, water scarcity and healthcare issues persist.

Drastic measures had to be taken to avoid the total collapse of the community-led monitoring programme.

Author's summary: SAHPRA approves lenacapavir for HIV prevention rollout.

more

Health-e News Health-e News — 2025-10-27